<DOC>
	<DOCNO>NCT01757483</DOCNO>
	<brief_summary>This study design evaluate effectiveness current ticagrelor risk minimisation strategy Canada prescriber knowledge understanding ( KAU ) survey select important identify safety concern ( i.e. , bleed , dyspnea drug interaction ) ASA dosage .</brief_summary>
	<brief_title>Canadian Ticagrelor Survey</brief_title>
	<detailed_description>Effectiveness risk minimisation intervention ticagrelor Canada</detailed_description>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>N/A ( All prescribers contact participation ) Participation previous wave survey .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>